Zacks Research Brokers Decrease Earnings Estimates for EMN

Key Points

• Zacks Research has lowered its FY2026 earnings estimate for Eastman Chemical to $7.21 per share, down from a previous forecast of $7.77, while the consensus estimate is $8.55 per share.
• Several analysts have decreased their price targets for Eastman Chemical's stock, with Royal Bank of Canada lowering its target from $91.00 to $74.00.
• The company reported a Q2 EPS of $1.60, falling short of the consensus estimate of $1.72, with revenue of $2.29 billion, reflecting a 3.2% decrease from the previous year.

Eastman Chemical Company (NYSE:EMN - Free Report) - Equities research analysts at Zacks Research reduced their FY2026 earnings per share estimates for shares of Eastman Chemical in a report issued on Wednesday, August 13th. Zacks Research analyst R. Department now expects that the basic materials company will post earnings of $7.21 per share for the year, down from their prior estimate of $7.77. The consensus estimate for Eastman Chemical's current full-year earnings is $8.55 per share. Zacks Research also issued estimates for Eastman Chemical's Q4 2026 earnings at $1.86 EPS, Q1 2027 earnings at $2.02 EPS, Q2 2027 earnings at $1.94 EPS and FY2027 earnings at $8.08 EPS.

EMN has been the subject of a number of other reports. Wall Street Zen lowered Eastman Chemical from a "buy" rating to a "hold" rating in a research note on Monday, April 28th. Wells Fargo & Company reduced their price target on Eastman Chemical from $90.00 to $70.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Morgan Stanley reduced their target price on Eastman Chemical from $125.00 to $115.00 and set an "overweight" rating on the stock in a research report on Monday, April 28th. KeyCorp set a $79.00 price target on Eastman Chemical and gave the company an "overweight" rating in a research note on Monday, August 4th. Finally, Citigroup dropped their price target on Eastman Chemical from $90.00 to $68.00 and set a "buy" rating on the stock in a research note on Monday, August 4th. Six research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, Eastman Chemical has an average rating of "Moderate Buy" and an average target price of $87.00.

Eastman Chemical Trading Down 1.2%

Shares of EMN stock traded down $0.79 on Thursday, reaching $65.61. 1,414,096 shares of the company's stock were exchanged, compared to its average volume of 2,096,200. Eastman Chemical has a 52 week low of $56.78 and a 52 week high of $114.50. The company has a current ratio of 1.68, a quick ratio of 0.78 and a debt-to-equity ratio of 0.81. The stock has a market capitalization of $7.53 billion, a PE ratio of 9.21, a P/E/G ratio of 6.26 and a beta of 1.21. The company's fifty day simple moving average is $74.27 and its 200 day simple moving average is $82.38.

Eastman Chemical (NYSE:EMN - Get Free Report) last announced its earnings results on Thursday, July 31st. The basic materials company reported $1.60 EPS for the quarter, missing analysts' consensus estimates of $1.72 by ($0.12). The company had revenue of $2.29 billion during the quarter, compared to analysts' expectations of $2.32 billion. Eastman Chemical had a return on equity of 15.24% and a net margin of 8.96%. Eastman Chemical's revenue for the quarter was down 3.2% compared to the same quarter last year. During the same quarter last year, the firm posted $2.15 EPS.

Institutional Investors Weigh In On Eastman Chemical

A number of institutional investors and hedge funds have recently modified their holdings of EMN. Holderness Investments Co. grew its stake in shares of Eastman Chemical by 1.2% during the first quarter. Holderness Investments Co. now owns 10,466 shares of the basic materials company's stock valued at $922,000 after acquiring an additional 125 shares in the last quarter. CX Institutional grew its stake in shares of Eastman Chemical by 10.6% during the second quarter. CX Institutional now owns 1,339 shares of the basic materials company's stock valued at $100,000 after acquiring an additional 128 shares in the last quarter. Wesbanco Bank Inc. grew its stake in shares of Eastman Chemical by 3.3% during the second quarter. Wesbanco Bank Inc. now owns 4,109 shares of the basic materials company's stock valued at $307,000 after acquiring an additional 130 shares in the last quarter. Y.D. More Investments Ltd grew its stake in shares of Eastman Chemical by 15.0% during the first quarter. Y.D. More Investments Ltd now owns 1,044 shares of the basic materials company's stock valued at $92,000 after acquiring an additional 136 shares in the last quarter. Finally, Beverly Hills Private Wealth LLC grew its stake in shares of Eastman Chemical by 4.5% during the first quarter. Beverly Hills Private Wealth LLC now owns 3,304 shares of the basic materials company's stock valued at $291,000 after acquiring an additional 143 shares in the last quarter. Institutional investors and hedge funds own 83.65% of the company's stock.

Eastman Chemical Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 7th. Investors of record on Monday, September 15th will be issued a $0.83 dividend. The ex-dividend date is Monday, September 15th. This represents a $3.32 dividend on an annualized basis and a dividend yield of 5.1%. Eastman Chemical's dividend payout ratio is currently 46.63%.

About Eastman Chemical

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.